Skip to content
Tech News
← Back to articles

Kinney Drugs pulls back AI phone assistant after hundreds of customer complaints

read original more articles
Why This Matters

Kinney Drugs has scaled back its AI phone assistant, Burt, following numerous customer complaints about inaccuracies and privacy concerns. The company is reverting to traditional phone systems for patient calls while retaining some AI features for outbound messages, emphasizing the importance of user trust and data security in healthcare technology. This incident highlights the challenges of implementing AI in sensitive sectors like healthcare, underscoring the need for rigorous testing and privacy safeguards.

Key Takeaways

Add Us On Google Add as a preferred source on Google

BURLINGTON, Vt. (WCAX) - Kinney Drugs is scaling back its AI assistant after customers reported incoherent calls, wrong dosages, and missed prescription notifications.

Kinney Drugs first introduced Burt, an AI assistant named after the pharmacy chain’s founder, back in May. The bot’s role was to communicate with patients about prescriptions and refills. But customers quickly reported a number of issues with the tech, as first reported by VTDigger.

“But one thing I want to point out is getting privacy and security right does not mean we got the experience right. We did not, and we own that,” Kinney Drugs President John Marraffa said.

Marraffa says Kinney will return to its old model for incoming patient calls — the classic touch-tone phone system.

Customers also raised concerns about data privacy — worried their personal health information could be exposed through an AI platform. Marraffa says Burt is fully HIPAA compliant and that the AI is not open-source and does not generate or manipulate data.

Kinney will keep Burt for outbound communications like prescription refill texts, but patients must opt in to receive them.